These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8520086)

  • 21. [Port device central venous access in children with chronic renal disease--personal experience].
    Szczepańska M; Szprynger K; Stoksik P; Morawiec-Knysak A; Adamczyk P; Ziora K; Oswiecimska J
    Wiad Lek; 2006; 59(11-12):814-8. PubMed ID: 17427497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients.
    Bertoglio S; Solari N; Meszaros P; Vassallo F; Bonvento M; Pastorino S; Bruzzi P
    Cancer Nurs; 2012; 35(4):E35-42. PubMed ID: 22228390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports.
    Carlo JT; Lamont JP; McCarty TM; Livingston S; Kuhn JA
    Am J Surg; 2004 Dec; 188(6):722-7. PubMed ID: 15619490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peripherally implanted permanent central venous access device.
    Morris P; Buller R; Kendall S; Anderson B
    Obstet Gynecol; 1991 Dec; 78(6):1138-42. PubMed ID: 1945224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of hydrochloric acid to restore patency in an occluded implantable port: a case report.
    Kupensky DT
    J Intraven Nurs; 1995; 18(4):198-201. PubMed ID: 7629640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piggyback compatibility of antibiotics with pediatric parenteral nutrition solutions.
    Watson D
    JPEN J Parenter Enteral Nutr; 1985; 9(2):220-4. PubMed ID: 3921739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanisms of failure of totally implantable central venous access system: analysis of 73 cases with fracture of catheter.
    Lin CH; Wu HS; Chan DC; Hsieh CB; Huang MH; Yu JC
    Eur J Surg Oncol; 2010 Jan; 36(1):100-3. PubMed ID: 19709847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compatibility and pH variability of four injectable phenytoin sodium products.
    Markowsky SJ; Kohls PR; Ehresman D; Leppik I
    Am J Hosp Pharm; 1991 Mar; 48(3):510-4. PubMed ID: 2028998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up of radiologically totally implanted central venous access ports of the upper arm: long-term complications in 127,750 catheter-days.
    Busch JD; Herrmann J; Heller F; Derlin T; Koops A; Adam G; Habermann CR
    AJR Am J Roentgenol; 2012 Aug; 199(2):447-52. PubMed ID: 22826411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro study of simultaneous infusion of incompatible drugs in multilumen catheters.
    Collins JL; Lutz RJ
    Heart Lung; 1991 May; 20(3):271-7. PubMed ID: 1903369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies.
    Cohn DE; Mutch DG; Rader JS; Farrell M; Awantang R; Herzog TJ
    Gynecol Oncol; 2001 Dec; 83(3):533-6. PubMed ID: 11733967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case presentation: precipitate in the central venous line: what went wrong?
    Flurkey H
    Neonatal Netw; 1994 Feb; 13(1):51-5. PubMed ID: 8114660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of central vein stenosis and occlusion following upper extremity PICC and port placement.
    Gonsalves CF; Eschelman DJ; Sullivan KL; DuBois N; Bonn J
    Cardiovasc Intervent Radiol; 2003; 26(2):123-7. PubMed ID: 12616419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for phenytoin infusions.
    Tuttle CB
    Can J Hosp Pharm; 1984; 37(4):137-9. PubMed ID: 10269318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallization of three phenytoin preparations in intravenous solutions.
    Giacona N; Bauman JL; Siepler JK
    Am J Hosp Pharm; 1982 Apr; 39(4):630-4. PubMed ID: 7081239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective study of a single treatment strategy for local tumescent anesthesia in Muller phlebectomy.
    Krasznai AG; Sigterman TA; Willems CE; Dekkers P; Snoeijs MG; Wittens CH; Sikkink CJ; Bouwman LH
    Ann Vasc Surg; 2015 Apr; 29(3):586-93. PubMed ID: 25595104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration-time profile of phenytoin after admixture with small volumes of intravenous fluids.
    Cloyd JC; Bosch DE; Sawchuk RJ
    Am J Hosp Pharm; 1978 Jan; 35(1):45-8. PubMed ID: 623117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing precipitation of pH-adjusted bupivacaine solutions.
    Bourget P; Bonhomme L; Benhamou D
    J Clin Pharm Ther; 1990 Jun; 15(3):197-204. PubMed ID: 2164035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of local instillation of recombinant tissue plasminogen activator for restoring occluded central venous catheters in neonates.
    Soylu H; Brandão LR; Lee KS
    J Pediatr; 2010 Feb; 156(2):197-201.e1. PubMed ID: 19969306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.